HLB이노베이션 Stock: price and insider trades · South Korea

This page follows insider dealings at HLB이노베이션 as filed with DART (FSS), a company from the Health Care sector. The last twelve months, up to 18 October 2026, brought 26 filings signed by 7 insiders.

Purchases and sales both appear in the filings: 19 purchases (5 insiders, €8.4M) and 6 sales (4 insiders). The totals exclude 18 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The buyers include 1 major shareholder and 1 board member. One trade stands out by size: a purchase of €4.8M from Hlb, disclosed on 15 May 2026, or 1.7% of market capitalisation.

Across the 2,648 companies tracked on its exchange, the median is 7 filings; at 26 filings, this issuer sits above that mark. Our records for HLB이노베이션 go back to 2021, with 53 purchases and 7 sales on the open market in total.

In the case of 7 purchases, another manager of the company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The most recent open-market purchase was published on 8 September 2026, 40 days ago. Filings reach the DART (FSS) feed a median of 5 days after the trade. That lag is the time during which only the insider knows about the trade.

Other companies in the same sector with recent insider buying flagged by our signals: Cooper Companies, Inc. and Cytosorbents Corp. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.